Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

TCMD vs CNMD

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
TCMD
Tactile Systems Technology, Inc.

Medical - Devices

HealthcareNASDAQ • US
Market Cap$587M
5Y Perf.-46.3%
CNMD
CONMED Corporation

Medical - Devices

HealthcareNYSE • US
Market Cap$1.17B
5Y Perf.-48.1%

TCMD vs CNMD — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
TCMD logoTCMD
CNMD logoCNMD
IndustryMedical - DevicesMedical - Devices
Market Cap$587M$1.17B
Revenue (TTM)$344M$1.37B
Net Income (TTM)$20M$55M
Gross Margin75.7%53.6%
Operating Margin9.4%11.3%
Forward P/E22.8x8.7x
Total Debt$16M$835M
Cash & Equiv.$83M$41M

TCMD vs CNMDLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

TCMD
CNMD
StockMay 20May 26Return
Tactile Systems Tec… (TCMD)10053.7-46.3%
CONMED Corporation (CNMD)10051.9-48.1%

Price return only. Dividends and distributions are not included.

Quick Verdict: TCMD vs CNMD

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: TCMD leads in 5 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. CONMED Corporation is the stronger pick specifically for valuation and capital efficiency and dividend income and shareholder returns. As sector peers, any of these can serve as alternatives in the same allocation.
TCMD
Tactile Systems Technology, Inc.
The Income Pick

TCMD carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • Dividend streak 1 yrs, beta 0.99
  • Rev growth 12.5%, EPS growth 17.1%, 3Y rev CAGR 10.1%
  • 134.7% 10Y total return vs CNMD's 6.6%
Best for: income & stability and growth exposure
CNMD
CONMED Corporation
The Value Play

CNMD is the clearest fit if your priority is value and dividends.

  • Lower P/E (8.7x vs 22.8x)
  • 2.1% yield; 2-year raise streak; the other pay no meaningful dividend
Best for: value and dividends
See the full category breakdown
CategoryWinnerWhy
GrowthTCMD logoTCMD12.5% revenue growth vs CNMD's 5.2%
ValueCNMD logoCNMDLower P/E (8.7x vs 22.8x)
Quality / MarginsTCMD logoTCMD5.9% margin vs CNMD's 4.0%
Stability / SafetyTCMD logoTCMDBeta 0.99 vs CNMD's 1.34, lower leverage
DividendsCNMD logoCNMD2.1% yield; 2-year raise streak; the other pay no meaningful dividend
Momentum (1Y)TCMD logoTCMD+169.8% vs CNMD's -31.3%
Efficiency (ROA)TCMD logoTCMD7.5% ROA vs CNMD's 2.4%, ROIC 13.8% vs 5.8%

TCMD vs CNMD — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

TCMDTactile Systems Technology, Inc.
FY 2025
Sales revenue
88.8%$293M
Rental revenue
11.2%$37M
CNMDCONMED Corporation
FY 2025
General Surgery
58.2%$800M
Orthopedic Surgery
41.8%$575M

TCMD vs CNMD — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLTCMDLAGGINGCNMD

Income & Cash Flow (Last 12 Months)

TCMD leads this category, winning 4 of 6 comparable metrics.

CNMD is the larger business by revenue, generating $1.4B annually — 4.0x TCMD's $344M. Profitability is closely matched — net margins range from 5.9% (TCMD) to 4.0% (CNMD). On growth, TCMD holds the edge at +22.8% YoY revenue growth, suggesting stronger near-term business momentum.

MetricTCMD logoTCMDTactile Systems T…CNMD logoCNMDCONMED Corporation
RevenueTrailing 12 months$344M$1.4B
EBITDAEarnings before interest/tax$39M$219M
Net IncomeAfter-tax profit$20M$55M
Free Cash FlowCash after capex$39M$124M
Gross MarginGross profit ÷ Revenue+75.7%+53.6%
Operating MarginEBIT ÷ Revenue+9.4%+11.3%
Net MarginNet income ÷ Revenue+5.9%+4.0%
FCF MarginFCF ÷ Revenue+11.4%+9.0%
Rev. Growth (YoY)Latest quarter vs prior year+22.8%-0.7%
EPS Growth (YoY)Latest quarter vs prior year+38.5%+136.8%
TCMD leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

CNMD leads this category, winning 6 of 6 comparable metrics.

At 25.2x trailing earnings, CNMD trades at a 20% valuation discount to TCMD's 31.7x P/E. On an enterprise value basis, CNMD's 10.2x EV/EBITDA is more attractive than TCMD's 14.5x.

MetricTCMD logoTCMDTactile Systems T…CNMD logoCNMDCONMED Corporation
Market CapShares × price$587M$1.2B
Enterprise ValueMkt cap + debt − cash$519M$2.0B
Trailing P/EPrice ÷ TTM EPS31.72x25.22x
Forward P/EPrice ÷ next-FY EPS est.22.82x8.71x
PEG RatioP/E ÷ EPS growth rate0.69x
EV / EBITDAEnterprise value multiple14.45x10.17x
Price / SalesMarket cap ÷ Revenue1.78x0.85x
Price / BookPrice ÷ Book value/share2.77x1.15x
Price / FCFMarket cap ÷ FCF14.51x7.78x
CNMD leads this category, winning 6 of 6 comparable metrics.

Profitability & Efficiency

TCMD leads this category, winning 9 of 9 comparable metrics.

TCMD delivers a 9.7% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $5 for CNMD. TCMD carries lower financial leverage with a 0.07x debt-to-equity ratio, signaling a more conservative balance sheet compared to CNMD's 0.81x. On the Piotroski fundamental quality scale (0–9), TCMD scores 8/9 vs CNMD's 5/9, reflecting strong financial health.

MetricTCMD logoTCMDTactile Systems T…CNMD logoCNMDCONMED Corporation
ROE (TTM)Return on equity+9.7%+5.4%
ROA (TTM)Return on assets+7.5%+2.4%
ROICReturn on invested capital+13.8%+5.8%
ROCEReturn on capital employed+11.9%+7.0%
Piotroski ScoreFundamental quality 0–985
Debt / EquityFinancial leverage0.07x0.81x
Net DebtTotal debt minus cash-$67M$794M
Cash & Equiv.Liquid assets$83M$41M
Total DebtShort + long-term debt$16M$835M
Interest CoverageEBIT ÷ Interest expense76.34x5.20x
TCMD leads this category, winning 9 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

TCMD leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in TCMD five years ago would be worth $4,652 today (with dividends reinvested), compared to $2,902 for CNMD. Over the past 12 months, TCMD leads with a +169.8% total return vs CNMD's -31.3%. The 3-year compound annual growth rate (CAGR) favors TCMD at 11.5% vs CNMD's -31.1% — a key indicator of consistent wealth creation.

MetricTCMD logoTCMDTactile Systems T…CNMD logoCNMDCONMED Corporation
YTD ReturnYear-to-date-5.1%-6.0%
1-Year ReturnPast 12 months+169.8%-31.3%
3-Year ReturnCumulative with dividends+38.8%-67.3%
5-Year ReturnCumulative with dividends-53.5%-71.0%
10-Year ReturnCumulative with dividends+134.7%+6.6%
CAGR (3Y)Annualised 3-year return+11.5%-31.1%
TCMD leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

TCMD leads this category, winning 2 of 2 comparable metrics.

TCMD is the less volatile stock with a 0.99 beta — it tends to amplify market swings less than CNMD's 1.34 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. TCMD currently trades 68.9% from its 52-week high vs CNMD's 62.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricTCMD logoTCMDTactile Systems T…CNMD logoCNMDCONMED Corporation
Beta (5Y)Sensitivity to S&P 5000.99x1.34x
52-Week HighHighest price in past year$37.75$61.08
52-Week LowLowest price in past year$9.34$33.21
% of 52W HighCurrent price vs 52-week peak+68.9%+62.4%
RSI (14)Momentum oscillator 0–10053.949.6
Avg Volume (50D)Average daily shares traded279K406K
TCMD leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

CNMD leads this category, winning 1 of 1 comparable metric.

Wall Street rates TCMD as "Buy" and CNMD as "Hold". Consensus price targets imply 104.8% upside for CNMD (target: $78) vs 49.0% for TCMD (target: $39). CNMD is the only dividend payer here at 2.09% yield — a key consideration for income-focused portfolios.

MetricTCMD logoTCMDTactile Systems T…CNMD logoCNMDCONMED Corporation
Analyst RatingConsensus buy/hold/sellBuyHold
Price TargetConsensus 12-month target$38.75$78.00
# AnalystsCovering analysts1121
Dividend YieldAnnual dividend ÷ price+2.1%
Dividend StreakConsecutive years of raises12
Dividend / ShareAnnual DPS$0.79
Buyback YieldShare repurchases ÷ mkt cap+4.5%0.0%
CNMD leads this category, winning 1 of 1 comparable metric.
Key Takeaway

TCMD leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CNMD leads in 2 (Valuation Metrics, Analyst Outlook).

Best OverallTactile Systems Technology,… (TCMD)Leads 4 of 6 categories
Loading custom metrics...

TCMD vs CNMD: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is TCMD or CNMD a better buy right now?

For growth investors, Tactile Systems Technology, Inc.

(TCMD) is the stronger pick with 12. 5% revenue growth year-over-year, versus 5. 2% for CONMED Corporation (CNMD). CONMED Corporation (CNMD) offers the better valuation at 25. 2x trailing P/E (8. 7x forward), making it the more compelling value choice. Analysts rate Tactile Systems Technology, Inc. (TCMD) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — TCMD or CNMD?

On trailing P/E, CONMED Corporation (CNMD) is the cheapest at 25.

2x versus Tactile Systems Technology, Inc. at 31. 7x. On forward P/E, CONMED Corporation is actually cheaper at 8. 7x.

03

Which is the better long-term investment — TCMD or CNMD?

Over the past 5 years, Tactile Systems Technology, Inc.

(TCMD) delivered a total return of -53. 5%, compared to -71. 0% for CONMED Corporation (CNMD). Over 10 years, the gap is even starker: TCMD returned +134. 7% versus CNMD's +6. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — TCMD or CNMD?

By beta (market sensitivity over 5 years), Tactile Systems Technology, Inc.

(TCMD) is the lower-risk stock at 0. 99β versus CONMED Corporation's 1. 34β — meaning CNMD is approximately 34% more volatile than TCMD relative to the S&P 500. On balance sheet safety, Tactile Systems Technology, Inc. (TCMD) carries a lower debt/equity ratio of 7% versus 81% for CONMED Corporation — giving it more financial flexibility in a downturn.

05

Which is growing faster — TCMD or CNMD?

By revenue growth (latest reported year), Tactile Systems Technology, Inc.

(TCMD) is pulling ahead at 12. 5% versus 5. 2% for CONMED Corporation (CNMD). On earnings-per-share growth, the picture is similar: Tactile Systems Technology, Inc. grew EPS 17. 1% year-over-year, compared to -64. 6% for CONMED Corporation. Over a 3-year CAGR, TCMD leads at 10. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — TCMD or CNMD?

Tactile Systems Technology, Inc.

(TCMD) is the more profitable company, earning 5. 8% net margin versus 3. 4% for CONMED Corporation — meaning it keeps 5. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CNMD leads at 10. 3% versus 8. 9% for TCMD. At the gross margin level — before operating expenses — TCMD leads at 75. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is TCMD or CNMD more undervalued right now?

On forward earnings alone, CONMED Corporation (CNMD) trades at 8.

7x forward P/E versus 22. 8x for Tactile Systems Technology, Inc. — 14. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CNMD: 104. 8% to $78. 00.

08

Which pays a better dividend — TCMD or CNMD?

In this comparison, CNMD (2.

1% yield) pays a dividend. TCMD does not pay a meaningful dividend and should not be held primarily for income.

09

Is TCMD or CNMD better for a retirement portfolio?

For long-horizon retirement investors, CONMED Corporation (CNMD) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (2.

1% yield). Both have compounded well over 10 years (CNMD: +6. 6%, TCMD: +134. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between TCMD and CNMD?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

CNMD pays a dividend while TCMD does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

TCMD

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 11%
  • Net Margin > 5%
Run This Screen
Stocks Like

CNMD

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 32%
  • Dividend Yield > 0.8%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform TCMD and CNMD on the metrics below

Revenue Growth>
%
(TCMD: 22.8% · CNMD: -0.7%)
Net Margin>
%
(TCMD: 5.9% · CNMD: 4.0%)
P/E Ratio<
x
(TCMD: 31.7x · CNMD: 25.2x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.